Accumulus Technologies

Accumulus Technologies builds a cloud platform that connects biopharma companies with global health authorities, so regulatory information reaches every party at the same time, securely and in real time. Its customers are large drugmakers such as Amgen, AstraZeneca, GSK, Lilly, Merck, Roche and Takeda, and the goal is to speed up regulatory decisions and patients' access to medicines. The platform was incubated inside the nonprofit industry association Accumulus Synergy and later spun out as a commercial company along with its team. Accumulus is fully remote and says it intends to stay that way, and PMs here work on products for a highly regulated, cross-border industry.